Viewing Study NCT04890106


Ignite Creation Date: 2025-12-26 @ 2:38 PM
Ignite Modification Date: 2025-12-26 @ 2:38 PM
Study NCT ID: NCT04890106
Status: COMPLETED
Last Update Posted: 2022-12-13
First Post: 2021-05-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGANĀ® In The Treatment of Chronic Open-Angle Glaucoma
Sponsor: Mankind Pharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module